Table 1.
Preoperative Patients' Characteristics
| Characteristics | Median (IQR) |
|---|---|
| Sample size (n) | 157 |
| Age (years) | 63 (59–68) |
| BMI (kg/m2) | 27.8 (25.8–29.6) |
| PSA (ng/mL) | 6.3 (4.7–8.2) |
| AUAss | 7 (3–14) |
| SHIM | 19 (12–24) |
| Count (%) | |
|---|---|
| Race | |
| Caucasian | 138 (87.9) |
| African American | 8 (5.1) |
| Others | 11 (7.0) |
| Clinical staging | |
| T1c | 154 (98.1) |
| T2a | 3 (1.9) |
| Clinical Gleason score | |
| 3 + 3 (GG1) | 39 (24.8) |
| 3 + 4 (GG2) | 83 (52.9) |
| 4 + 3 (GG3) | 13 (8.3) |
| ≥8 (GG4 or GG5) | 22 (14.0) |
| Pathologic Gleason score | |
| 6 | 17 (10.8) |
| 7 | 127 (80.9) |
| 8 | 7 (4.5) |
| 9 | 6 (3.8) |
| Pathologic stage | |
| T2 | 119 (75.8) |
| T3a | 33 (21.0) |
| T3b | 5 (3.2) |
AUAss = American Urological Association symptom score; BMI = body mass index; GG = Grade Group; IQR = interquartile range; PSA = prostate-specific antigen; SHIM = sexual health inventory for men.